Pancreatic Supplement

Verify with FDA CVM →

20 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
20
Total Reports
2
Deaths Reported
1000.0%
Death Rate

Active Ingredients

Pancreatic Supplement

Administration Routes

UnknownOralOther

Species Affected

Dog 20

Most Affected Breeds

Shepherd Dog - German 8
Pekingese 2
Terrier - West Highland White 1
Dog (unknown) 1
Setter - Gordon 1
Retriever - Labrador 1
Spaniel - Cocker American 1
Collie (unspecified) 1
Dachshund - Miniature 1
Collie - Border 1

Most Reported Reactions

Emesis 5
Lack of efficacy - NOS 4
Vomiting 3
Not drinking 3
Elevated blood urea nitrogen (BUN) 3
Elevated alanine aminotransferase (ALT) 3
Tachycardia 3
Weakness 3
Dry mucous membrane 3
Enophthalmos (see also Sunken eyes in Systemic disorders) 3
Itching 2
Lethargy (see also Central nervous system depression in 'Neurological') 2

Outcome Breakdown

Outcome Unknown
7 (35.0%)
Recovered/Normal
5 (25.0%)
Recovered with Sequela
3 (15.0%)
Ongoing
3 (15.0%)
Died
2 (10.0%)

Data Summary

Metric Value
Total adverse event reports 20
Reports involving death 2
Case-fatality rate (reported events) 1000.0%
Distinct species in reports 1
Distinct breeds in reports 12
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Pancreatic Supplement Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 20 adverse event reports referencing Pancreatic Supplement, including 2 reports in which the animal died — a 1000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Pancreatic Supplement. Reported administration routes include Unknown, Oral, Other. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Pancreatic Supplement reports are Dog (20 reports), with Dog accounting for the largest share. Within those species, Shepherd Dog - German (8), Pekingese (2), Terrier - West Highland White (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Pancreatic Supplement are Emesis (5), Lack of efficacy - NOS (4), Vomiting (3), Not drinking (3). Of the 20 reports with a coded outcome, Outcome Unknown is the leading category at 35.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Pancreatic Supplement.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial